Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK).

Saved in:
Bibliographic Details
Title: Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK).
Authors: Hernando J; Department of Medical Oncology, Hepatobiliary Pancreatic Cancer and Endocrine Tumors, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Neuroendocrine and Endocrine Tumor Translational Research Program (NET-VHIO), Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Electronic address: jhernando@vhio.net., Lopez C; Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, UNICAN, Santander, Spain., Garcia-Alvarez A; Department of Medical Oncology, Hepatobiliary Pancreatic Cancer and Endocrine Tumors, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Neuroendocrine and Endocrine Tumor Translational Research Program (NET-VHIO), Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Aguín Losada S; Medical Oncology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Martínez-Sáez O; Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain., Gonzalez-Perez C; Department of Pediatric Hematology and Oncology, Hospital Universitario La Paz, Madrid, Spain., López-Almaraz R; Pediatric Oncology/Haematology Unit, Hospital Universitario Cruces & Biobizkaia Health Research Institute, Barakaldo, Spain., Sánchez Morillas R; Medical Oncology, Hospital Universitario Son Espases, Palma, Spain., Rebollo Liceaga J; Medical Oncology, Hospital Quirón Salud Torrevieja, Torrevieja, Spain., Ferreira Freire L; Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., Pavon-Mengual M; Pediatric Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Ruiz Vico M; Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., López-Gómez M; Medical Oncology, Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain., Morilla I; Medical Oncology, Hospital Universitario de Navarra, Pamplona, Spain., Rodríguez-Abreu D; Medical Oncology, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Capdevila J; Department of Medical Oncology, Hepatobiliary Pancreatic Cancer and Endocrine Tumors, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Neuroendocrine and Endocrine Tumor Translational Research Program (NET-VHIO), Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Mar 11; Vol. 236, pp. 116252. Date of Electronic Publication: 2026 Jan 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2026.116252